Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.15 and traded as low as $0.14. Elite Pharmaceuticals shares last traded at $0.14, with a volume of 245,027 shares trading hands.
Elite Pharmaceuticals Price Performance
The stock has a market cap of $149.43 million, a PE ratio of 13.99 and a beta of -0.16. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.94 and a quick ratio of 1.19. The business has a fifty day moving average of $0.16 and a 200-day moving average of $0.15.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Recommended Stories
- Five stocks we like better than Elite Pharmaceuticals
- Insider Buying Explained: What Investors Need to Know
- Here are the Pros and Cons of Using Options Call Debit Spreads
- Short Selling: How to Short a Stock
- Carmax Returns to the Bargain Basement: Buy the Dip?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s Down
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
